Inferior Alveolar Nerve Block Success of 2% Mepivacaine vs 4% Articaine in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Endodontic Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial
Int Endod J 2022 Aug 10;[EPub Ahead of Print], MFOM Habib, S Tarek, SME Teama, K Ezzat, RM El Boghdadi, A Marzouk, MY Fouda, SI Gawdat, MM Bedier, SAW AminFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.